Compares two treatments for chronic migraine in adults
Tests a nerve block against BOTOX injections in adults with chronic migraine.
Plain-language title generated from the registry record
Registry title: Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06974617, who can take part
Where in Egypt
- Cairo UniversityCairo, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cairo University
- Trial code
- NCT06974617
- Record updated
- 16 May 2025
- Original description
This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.Read full original descriptionShow less
Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine: A Randomized Clinical Trial
This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.
Inclusion: Age 18 and 65 years; Both sexes; Chronic migraine. Chronic migraine, defined as headaches on ≥15 days per month for ≥3 months, of which ≥8 days meet criteria for migraine without aura or respond to migraine-specific treatment according to International Classification of Headache Disorders-3 Beta.
Exclusion: Patients with medication over use headache; Bleeding disorders; History of allergy to local anesthetics or BOTOX; Abnormal neurological examination.